Tag: synthetic lethality in cancer treatment

In an extraordinary leap forward for cancer pharmacology, recent research has illuminated a previously uncharacterized mechanism driving the uneven distribution ...

Recent advancements in cancer therapies have illuminated the complex biological pathways intertwined with treatment responses. Among them, ovarian cancer remains ...

The emergence of poly(ADP-ribose) polymerase inhibitors (PARPi) as a transformative therapy for homologous recombination-deficient tumors has significantly altered the landscape ...